59 related articles for article (PubMed ID: 11576461)
21. Acute exacerbation during interferon alfa treatment of chronic hepatitis B: frequency and relation to serum beta-2 microglobulin levels.
Akdogan M; Senturk H; Mert A; Tabak F; Ozbay G
J Gastroenterol; 2003; 38(5):465-70. PubMed ID: 12768389
[TBL] [Abstract][Full Text] [Related]
22. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
[TBL] [Abstract][Full Text] [Related]
23. High-dose interferon results in high HBsAg seroclearance in children with chronic hepatitis B infection.
Ertem D; Acar Y; Kotiloğlu Karaa E; Pehlivanoğlu E
Turk J Pediatr; 2003; 45(2):123-8. PubMed ID: 12921298
[TBL] [Abstract][Full Text] [Related]
24. Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients?
Alavi-Moghaddam M; Alavian SM; Aalaei-Andabili SH; Eslami-Far A
Vaccine; 2011 Nov; 29(48):9093-7. PubMed ID: 21893143
[TBL] [Abstract][Full Text] [Related]
25. [Factors related to chronic hepatitis B relapse after interferon-alpha treatment: a follow-up study].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1264-6, 1270. PubMed ID: 17715044
[TBL] [Abstract][Full Text] [Related]
26. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
Ristig MB; Crippin J; Aberg JA; Powderly WG; Lisker-Melman M; Kessels L; Tebas P
J Infect Dis; 2002 Dec; 186(12):1844-7. PubMed ID: 12447773
[TBL] [Abstract][Full Text] [Related]
27. [Effect of IL-12 on IFN-gamma and IL-10 produced by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection during IFN-alpha treatment].
Wang S; Lin Y; Ma W; Zhang B; Qi S; Lan F
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):116-9. PubMed ID: 11983129
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis C.
Di Fazio I; Motta M; Musumeci S; Neri S; Pistone G; Malaguarnera M
J Interferon Cytokine Res; 2004 Oct; 24(10):594-9. PubMed ID: 15626156
[TBL] [Abstract][Full Text] [Related]
29. Early response to interferon alpha treatment and long-term clinical outcome in Japanese patients with chronic HBV genotype C infection.
Seo Y; Yoon S; Hamano K; Nakaji M; Yano Y; Katayama M; Ninomiya T; Hayashi Y; Kasuga M
Int J Mol Med; 2004 Jan; 13(1):75-9. PubMed ID: 14654974
[TBL] [Abstract][Full Text] [Related]
30. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
[TBL] [Abstract][Full Text] [Related]
32. A longitudinal study of the efficacy of interferon therapy in children with chronic hepatitis B.
Kacprzak-Bergman I; Zaleska I; Gruszka J; Jasonek J
Med Sci Monit; 2002 Dec; 8(12):CR805-14. PubMed ID: 12503040
[TBL] [Abstract][Full Text] [Related]
33. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
[TBL] [Abstract][Full Text] [Related]
34. Interferon therapy of Turkish patients with chronic hepatitis B virus infection.
Besirbellioglu B; Gul C; Gorenek L; Eyigun CP; Hacibektasoglu A; Van Thiel DH
Hepatogastroenterology; 1999; 46(25):387-90. PubMed ID: 10228827
[TBL] [Abstract][Full Text] [Related]
35. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
[TBL] [Abstract][Full Text] [Related]
36. Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases.
Bruno CM; Neri S; Sciacca C; Bertino G; Di Prima P; Cilio D; Pellicano R; Caruso L; Cristaldi R
World J Gastroenterol; 2004 May; 10(9):1353-6. PubMed ID: 15112358
[TBL] [Abstract][Full Text] [Related]
37. Effects of 100-km ultramarathon on erythropoietin variation in runners with hepatitis B virus carrier.
Li LH; Chiu YH; Meng C; Kao WF; How CK
Chin J Physiol; 2021; 64(3):125-128. PubMed ID: 34169917
[TBL] [Abstract][Full Text] [Related]
38. Plasma erythropoietin in essential thrombocythaemia: at diagnosis and in response to myelosuppressive treatment.
Andréasson B; Lindstedt G; Kutti J
Leuk Lymphoma; 2000 Jun; 38(1-2):113-20. PubMed ID: 10811453
[TBL] [Abstract][Full Text] [Related]
39. Serum-erythropoietin concentration during acute cardiogenic pulmonary edema.
Kurz RW; Stockenhuber F; Jahn C; Wurnig C; Balcke P
Angiology; 1991 Apr; 42(4):281-8. PubMed ID: 2014919
[TBL] [Abstract][Full Text] [Related]
40. Correlation between erythropoietin and lactate in humans during altitude exposure.
Sakata S; Shimizu S; Kishi T; Hirai K; Mori I; Ohno Y; Ueda M; Takaki M; Kohzuki H; Okamoto S; Shimamoto I; Yanagi S; Ogoshi K; Sherchand JB
Jpn J Physiol; 2000 Apr; 50(2):285-8. PubMed ID: 10880888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
